Vontobel Holding Ltd. Gritstone Bio, Inc. Transaction History

Vontobel Holding Ltd.

  • $29.2 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Jun 03, 2024
BUY
$2.13 - $3.74 $149,100 - $261,800
70,000 New
70,000 $194,000
Q4 2022

Feb 14, 2023
BUY
$2.17 - $3.92 $43,400 - $78,400
20,000 Added 40.0%
70,000 $241,000
Q3 2022

Nov 04, 2022
BUY
$2.46 - $4.75 $123,000 - $237,500
50,000 New
50,000 $129,000

Others Institutions Holding GRTS

# of Institutions
61
Shares Held
35.4M
Call Options Held
395K
Put Options Held
132K
View Full List

About Gritstone bio, Inc.

GRTS Quotes by TradingView
  • Ticker GRTS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 73,006,896
  • Market Cap $2.19M
  • Description
  • Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing immunotherapies against multiple cancer types and infectious diseases. Its lead product candidate is GRANITE, a neoantigen-based immunotherapy for the treatment of solid tumors, including metastatic non-small cell lung cancer, as well as gastroesophageal, bladder ...
More about GRTS
Track This Portfolio

Track Vontobel Holding Ltd. Portfolio

Follow Vontobel Holding Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vontobel Holding Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Vontobel Holding Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email